World's Best Scientists 2026 revealed!
Takahiro Yamazaki

Takahiro Yamazaki

D-Index & Metrics

Immunology

D-Index
47
Citations
21128
World Ranking
4463
National Ranking
2019

Takahiro Yamazaki publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Takahiro Yamazaki sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 119 publications — 7th percentile

7% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Takahiro Yamazaki D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Takahiro Yamazaki sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 47 D-Index — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Takahiro Yamazaki is a researcher affiliated with Cornell University in the United States. Their scientific work primarily spans the fields of Medicine, Biochemistry, Genetics and Molecular Biology, and Immunology and Microbiology. Their research is further specialized in subfields such as Immunology, Oncology, Molecular Biology, Epidemiology, and Physiology.

The main topics of Takahiro Yamazaki's research include cancer immunotherapy and biomarkers, immunotherapy and immune responses, autophagy in disease and therapy, RNA interference and gene delivery, interferon and immune responses, CAR-T cell therapy research, and advanced breast cancer therapies.

They have contributed to a number of publications in various scientific venues. Frequent publication venues include:

  • Methods in cell biology
  • OncoImmunology
  • Communications Biology
  • Regular and Young Investigator Award Abstracts
  • Journal for ImmunoTherapy of Cancer

Some of Takahiro Yamazaki's recent papers are:

  • Consensus guidelines for the definition, detection and interpretation of immunogenic cell death, 2020, Journal for ImmunoTherapy of Cancer
  • Detection of immunogenic cell death and its relevance for cancer therapy, 2020, Cell Death and Disease
  • Mitochondrial control of inflammation, 2022, Nature reviews. Immunology
  • Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy, 2020, Nature Immunology
  • Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control, 2021, Journal of Clinical Investigation

Throughout their research career, Takahiro Yamazaki has collaborated frequently with several co-authors, including:

  • Lorenzo Galluzzi
  • Aitziber Buqué
  • Norma Bloy
  • Ai Sato
  • Silvia C. Formenti

Best Publications

  • Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

    Marie Vétizou;Marie Vétizou;Marie Vétizou;Jonathan M. Pitt;Jonathan M. Pitt;Jonathan M. Pitt;Romain Daillère;Romain Daillère;Romain Daillère;Patricia Lepage

  • The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide

    Sophie Viaud;Sophie Viaud;Fabiana Saccheri;Grégoire Mignot;Takahiro Yamazaki

  • Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

    Antonella Sistigu;Takahiro Yamazaki;Erika Vacchelli;Kariman Chaba

  • Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors

    Jonathan M. Pitt;Marie Vétizou;Marie Vétizou;Marie Vétizou;Romain Daillère;Romain Daillère;Romain Daillère;María Paula Roberti

  • Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

    Lorenzo Galluzzi;Ilio Vitale;Sarah Warren;Sandy Adjemian

  • Detection of immunogenic cell death and its relevance for cancer therapy

    Jitka Fucikova;Oliver Kepp;Lenka Kasikova;Giulia Petroni

  • Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy

    Christina Pfirschke;Camilla Engblom;Steffen Rickelt;Virna Cortez-Retamozo

  • Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects

    Romain Daillère;Romain Daillère;Romain Daillère;Marie Vétizou;Marie Vétizou;Marie Vétizou;Nadine Waldschmitt;Takahiro Yamazaki;Takahiro Yamazaki

  • Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells.

    Yuting Ma;Yuting Ma;Yuting Ma;Sandy Adjemian;Sandy Adjemian;Sandy Adjemian;Stephen R. Mattarollo;Takahiro Yamazaki;Takahiro Yamazaki;Takahiro Yamazaki

  • Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance

    Federico Pietrocola;Federico Pietrocola;Jonathan Pol;Erika Vacchelli;Erika Vacchelli;Shuan Rao

  • Linking cellular stress responses to systemic homeostasis

    Lorenzo Galluzzi;Takahiro Yamazaki;Guido Kroemer

  • An immunosurveillance mechanism controls cancer cell ploidy

    Laura Senovilla;Laura Senovilla;Laura Senovilla;Ilio Vitale;Ilio Vitale;Ilio Vitale;Isabelle Martins;Isabelle Martins;Isabelle Martins;Maximilien Tailler;Maximilien Tailler;Maximilien Tailler

  • Cardiac Glycosides Exert Anticancer Effects by Inducing Immunogenic Cell Death

    Laurie Menger;Erika Vacchelli;Erika Vacchelli;Erika Vacchelli;Sandy Adjemian;Sandy Adjemian;Sandy Adjemian;Isabelle Martins;Isabelle Martins;Isabelle Martins

  • Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy.

    Takahiro Yamazaki;Alexander Kirchmair;Ai Sato;Aitziber Buqué

  • Crizotinib-induced immunogenic cell death in non-small cell lung cancer

    Peng Liu;Liwei Zhao;Jonathan Pol;Sarah Levesque

  • Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists

    Takahiro Yamazaki;Dalil Hannani;Vichnou Poirier-Colame;Sylvain Ladoire

  • A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1

    Shin Foong Ngiow;Arabella Young;Arabella Young;Nicolas Jacquelot;Takahiro Yamazaki

  • Crosstalk between ER stress and immunogenic cell death.

    Oliver Kepp;Laurie Menger;Laurie Menger;Laurie Menger;Erika Vacchelli;Erika Vacchelli;Erika Vacchelli;Clara Locher;Clara Locher

  • Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade

    Nicolas Jacquelot;Takahiro Yamazaki;Maria P. Roberti;Connie P.M. Duong

  • Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control.

    Claire Lhuillier;Nils Petter Rudqvist;Takahiro Yamazaki;Tuo Zhang

  • Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy

    Heng Yang;Yuting Ma;Guo Chen;Heng Zhou

Frequent Co-Authors

Lorenzo Galluzzi
Lorenzo Galluzzi Cornell University
Guido Kroemer
Guido Kroemer Université Paris Cité
Laurence Zitvogel
Laurence Zitvogel University of Paris-Saclay
Oliver Kepp
Oliver Kepp Institut Gustave Roussy
Yuting Ma
Yuting Ma University of Oxford
Mark J. Smyth
Mark J. Smyth QIMR Berghofer Medical Research Institute
Erika Vacchelli
Erika Vacchelli Université Paris Cité
Aurélien Marabelle
Aurélien Marabelle Institut Gustave Roussy
Isabelle Martins
Isabelle Martins Inserm : Institut national de la santé et de la recherche médicale
Laura Senovilla
Laura Senovilla University of Valladolid

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees online can open diverse career paths. Many professionals consider advanced nursing programs as a stepping stone into specialized medical fields. Programs like the cheapest psych np programs offer an affordable route for nurses aiming to expand their expertise into psychiatric care, a field closely linked to immunological health.

Understanding earning potential can guide career decisions. For example, knowing how much do dnp nurses make helps prospective students evaluate the return on investment of pursuing a Doctor of Nursing Practice degree, which can complement immunology knowledge in clinical or research roles.

Transitioning roles is also a critical consideration. Programs such as those designed for an fnp to acute care np bridge program provide structured paths for Family Nurse Practitioners to shift into acute care settings, where immunological expertise is often essential.

Finally, accelerated nursing programs can fast-track careers. The accelerated np programs online enable qualified candidates to efficiently gain the credentials needed to work in specialties that intersect with immunology, enhancing both clinical skills and professional prospects.

Best Scientists Citing Takahiro Yamazaki

Trending Scientists

Recently Published Articles